NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?

Abstract

Get full access to this article

View all access options for this article.

References

Turan

. The nonalcoholic fatty liver disease fibrosis score is related to epicardial fat thickness and complexity of coronary artery disease. Angiology. 2019;71(1):77–82.

Angulo

Hui

Marchesini

et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54.

Zakeri

Tsochatzis

. Steatosis affects the sensitivity but not the specificity of non-invasive fibrosis tests in non-alcoholic fatty liver disease—implications for screening strategies. Liver Int. 2018;38(2):224–6.

Tsochatzis

Newsome

. Non-alcoholic fatty liver disease and the interface between primary and secondary care. Lancet Gastroenterol Hepatol. 2018;3(7):509–17.

Yilmaz

Kurt

Gurdal

et al. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis. 2011;217(1):125–9.

Sunbul

Agirbasli

Durmus

et al. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue. Atherosclerosis. 2014;237(2):490–3.